Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
作者信息
Lagrue G, Masbernard A, Giudicelli C, Hirbec G
出版信息
Arzneimittelforschung. 1974 Sep;24(9A SUPPL):1434-9.
PMID:4614821
Abstract
摘要
相似文献
1
Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
Arzneimittelforschung. 1974 Sep;24(9A SUPPL):1434-9.
2
[Results of clinical trials of calcium bucloxate (804 CB) in rheumatology].
Arzneimittelforschung. 1974 Sep;24(9A SUPPL):1425-8.
3
[Clinical experimentation of calcium bucloxate (804 CB) in rheumatology].
Arzneimittelforschung. 1974 Sep;24(9A SUPPL):1428-31.
4
[Action of a novel anti-inflammatory agent: 804 CB on Masugi type experimental glomerulonephritis].
Arzneimittelforschung. 1974 Sep;24(9A SUPPL):1378-84.
5
[Biological surveillance during a test of 804 CB in internal medicine. 120 observations].
Arzneimittelforschung. 1974 Sep;24(9A SUPPL):1442-4.
6
[Comparative study of 804 CB and phenylbutazone. Double blind test of venous and arterial pathology].
Arzneimittelforschung. 1974 Sep;24(9A SUPPL):1432-4.
7
[A new anti-inflammatory agent: calcium bucloxate in pediatrics].
Arzneimittelforschung. 1974 Sep;24(9A SUPPL):1440-2.
8
[Pharmacologic properties of a new, nonsteroidal anti-inflammatory agent, bucloxic acid (804 CB)].
Arzneimittelforschung. 1974 Sep;24(9A SUPPL):1368-78.
9
[Comparative study on the activity of various anti-inflammatory agents in chronically developing glomerulonephritis].
J Urol Nephrol (Paris). 1975 Sep;81(9):673-90.
10
[A new nonsteroidal anti-inflammatory agent: bucloxic acid (804 CB)].
Arzneimittelforschung. 1974 Sep;24(9A SUPPL):1364-7.
引用本文的文献
1
Renal survival in membranoproliferative glomerulonephritis (MPGN): role of long-term treatment with non-steroid anti-inflammatory drugs (NSAID).
Int Urol Nephrol. 1988;20(6):669-77. doi: 10.1007/BF02549501.
Zotero 插件